Genomic sequencing of the pituitary tumor (before chemotherapy) and liver metastasis (after chemotherapy) showed evidence of alkylating chemotherapy-induced somatic mutations with the presence of a MSH6 mutation in the TMZ-treated liver metastasis. Here, MSH6 is linked to pituitary tumor.